18th May 2022

CompanySymbol ProposedExpected to Trade 
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Inhibikase TherapeuticsIKT11/11/2020 WednesdayLearn More
Featured Articles

New to the Street Episode 258 | Innerscope, Boatim, FINXFLO,  Rego Payment Architectures, EQIFI, GlobeX, PetVivo, Sekur

New to The Street’s 258th T.V. show line-up, features eight interviews of the following Companies and their businesses representatives: New to The Street T.V. interviews Mr. Matthew Moore, CEO of InnerScope Hearing Technologies, Inc. (OTCPINK: INND). Talking with T.V....

Is this Small Cap Biotech going to Uplist to NASDAQ?

There is a niche biotech company called PetVivo, Holdings, Inc. (OTCQB: PETV) that has had a lot going on lately. They are an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets.  PetVivo is benefiting from...

This Niche Biotech Company is paving the way with a Sponsored Research Agreement

Biotech and the money flowing into biotech stocks has been 99.99% focused on a covid-19 Vaccine.  Pfizer (NYSE: PFE) has announced their vaccine with Moderna (NASAQ: MRNA) soon to follow.  Pfizer has had a great run from $35 to $42 and Moderna equaling in percentage...

New to the Street will present the premiere for Winston Gold Corp’s 6 part series

NEW YORK, NY / ACCESSWIRE / November 16, 2020 / New To The Street "Exploring The Block" is pleased to be broadcasting on Thursday at 1030 pm PST Featuring fetch.ai (FET), Winston Gold Corp.(WGMCF), GreenBoxPOS(GRBX), ZYNECOIN(ZYN) and AurusCoin(AWX) This show is the...

Videos

Latest News

PetVivo Holdings, Inc. Announces Sponsored Research Agreement with Colorado State University for Osteoarthritis Treatment Study.

MINNEAPOLIS, Nov. 12, 2020 (GLOBE NEWSWIRE) -- OTCQB: (PETV) PetVivo Holdings, Inc. (OTCQB: PETV) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce the entry into a sponsored...

Covid-19 Vaccine is here. Where can you still find Value in Biotech?

Originally posted at https://emerginggrowth.com/the-wild-west-2-0-montanas-newest-gold-mine-in-six-parts/ Pfizer (NYSE: PFE) just announced results that could pave the way for a covid-19 vaccine by year end. An article in Bloomberg stated: “The Covid-19 vaccine being...

The Wild West 2.0: The Winston Gold Project, Montana’s Newest Gold mine in Six Parts

Crossposted from New to the Street Located just one hour’s drive north Butte, of one the most historically significant mining towns in the US, and close to Helena, is Montana’s newest gold rush, and home to the Winston Gold Project. You don’t want to miss...

The Wild West 2.0: The Winston Gold Project, Montana’s Newest Gold mine in Six Parts

Located just one hour’s drive north Butte, of one the most historically significant mining towns in the US, and close to Helena, is Montana’s newest gold rush, and home to the Winston Gold Project. You don’t want to miss this six-part series featuring Winston Gold...

The best way to Profit in Biotech for the remainder of 2020

Nov 1, 2020

Investors Business Daily recently posted an article about “Finding the best biotech companies to invest in”.  The article goes on to say that investing in this field is tricky, clinical plans don’t always come to fruition, and biotech stocks can often suffer at the...

Out with the Old, In with New to The Street

Oct 2, 2020

Growing relationships with investors lead to more profitable and liquid investments.  But in the Covid-19 era, how can new relationships be established and current relationships flourish? Companies are now more than ever challenged to keep attracting a new audience...